Senior Consultant,

Department of Haematology, Singapore General Hospital

Chief Medical Officer,

Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)

Head, SingHealth Duke-NUS Cell Therapy Centre (SDCT)

Dr Lim spent 2 years training at MD Anderson Cancer Center on CAR T cell therapy particularly on CAR NK cell therapy under Professor Katy Rezvani as well as in the Good Manufacturing Processing Facility (GMP). Since her return from MD Anderson Cancer Center, Dr Lim has been instrumental in supporting and coordinating the Cell Therapy Program at SGH Haematology, SingHealth, both at the clinical, research and translational level. 

She specializes in Haematopoietic Stem cell Transplant and currently leads the Immune Effector Cell Therapy Clinical Programme at SGH. Dr Lim has spent the last 3 years setting up the IEC and CAR T cell Clinical Program at SGH. She has much clinical experience in selecting and managing patients who undergo IEC therapies especially CAR T cell therapies and has been actively involved in many scientific discussions and has assisted in the translation of innovative cellular therapies into the clinics.